Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochemistry

• Publication date

  2005-08-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI050660MPMID 16114889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.

  2004cited by this paper
• Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity.

  2004cited by this paper
• Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain

  2004cited by this paper
• (-)-FR182877 is a potent and selective inhibitor of carboxylesterase-1.

  2003cited by this paper
• An enantioselective synthesis of FR182877 provides a chemical rationalization of its structure and affords multigram quantities of its direct precursor.

  2003cited by this paper
• Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin.

  2003cited by this paper
• A cascade cycloaddition strategy leading to the total synthesis of (-)-FR182877.

  2002cited by this paper
• The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.

  2002cited by this paper
• Chemical synthesis and biological evaluation of novel epothilone B and trans-12,13-cyclopropyl epothilone B analogues

  2002cited by this paper
• A synthesis of (+)-FR182877, featuring tandem transannular Diels-Alder reactions inspired by a postulated biogenesis.

  2002cited by this paper
• Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.

  2002cited by this paper
• A New Antimitotic Substance, FR182877. Part 3. Structure Determination.

  2001cited by this paper
• The interaction of baccatin III with the taxol binding site of microtubules determined by a homogeneous assay with fluorescent taxoid.

  2001cited by this paper
• A new antimitotic substance, FR182877. II. The mechanism of action.

  2000cited by this paper
• A new antimitotic substance, FR182877. III. Structure determination.

  2000cited by this paper
• A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.

  2000influential reference
• Molecular Recognition of Taxol by Microtubules

  2000cited by this paper
• A new antimitotic substance, FR182877. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

  2000cited by this paper
• Hexacyclinic acid, a Polyketide from Streptomyces with a Novel Carbon Skeleton

  2000cited by this paper
• The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site.

  1999cited by this paper
• Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.

  1999cited by this paper
• Structure of the alpha beta tubulin dimer by electron crystallography.

  1998cited by this paper
• Role of the colchicine ring A and its methoxy groups in the binding to tubulin and microtubule inhibition.

  1998cited by this paper
• Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).

  1998cited by this paper
• Structure of the αβ tubulin dimer by electron crystallography

  1998cited by this paper
• Derivation of class II force fields: V. Quantum force field for amides, peptides, and related compounds

  1998influential reference
• Activities of the Microtubule-stabilizing Agents Epothilones A and B with Purified Tubulin and in Cells Resistant to Paclitaxel (Taxol®)*

  1997cited by this paper
• Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization*

  1997cited by this paper
• The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.

  1997cited by this paper
• Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.

  1996influential reference
• New Fluorescent Water‐Soluble Taxol Derivatives

  1996cited by this paper
• Differential effects of paclitaxel (Taxol) analogs modified at positions C-2, C-7, and C-3' on tubulin polymerization and polymer stabilization: identification of a hyperactive paclitaxel derivative.

  1995cited by this paper
• Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.

  1995cited by this paper
• Drug therapy : paclitaxel (Taxol)

  1995cited by this paper
• Microtubule dynamics: taking aim at a moving target.

  1995cited by this paper
• Paclitaxel (taxol)

  1995cited by this paper
• The magnesium-GTP interaction in microtubule assembly.

  1994cited by this paper
• Thermodynamics of ligand-induced assembly of tubulin.

  1993cited by this paper
• Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol.

  1991cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper
• Absence of 7‐acetyl taxol binding to unassembled brain tubulin

  1988cited by this paper
• Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

  1987cited by this paper
• Separation of active tubulin and microtubule-associated proteins by ultracentrifugation and isolation of a component causing the formation of microtubule bundles.

  1984cited by this paper
• Taxol binds to polymerized tubulin in vitro

  1981cited by this paper
• Assembly and disassembly properties of microtubules formed in the presence of GTP, 5'-guanylyl imidodiphosphate, and 5'-guanylyl methylenediphosphate.

  1980cited by this paper
• Enzymes. 3rd ed

  1979cited by this paper
• Promotion of microtubule assembly in vitro by taxol

  1979cited by this paper

• Crosstalk between Microtubule Stabilizing Agents and Prostate Cancer

  2023cites this paper
• Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment

  2021cites this paper
• The progress of the anticancer agents related to the microtubules target.

  2020cites this paper
• Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands

  2019cites this paper
• Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains.

  2019cites this paper
• Enantioselective Total Synthesis of the Antitumor Polycyclic Natural Products FR182877 and Taxol

  2019cites this paper
• Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule

  2019cites this paper
• Recent advances in microtubule-stabilizing agents.

  2018cites this paper
• A Stereocontrolled Annulation of the Taccalonolide Epoxy Lactone onto the Molecular Framework of trans-Androsterone.

  2017cites this paper
• Microtubule Targeting Agents in Cancer Therapy: Elucidating the Underlying Molecular Mechanisms

  2017cites this paper
• Chapter 11 – Microtubule Stabilization

  2016cites this paper
• Microtubule-stabilizing agents: New drug discovery and cancer therapy.

  2016cites this paper
• Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

  2014cites this paper
• Zampanolide and dactylolide: cytotoxic tubulin-assembly agents and promising anticancer leads

  2014cites this paper
• Methods for studying microtubule binding site interactions: zampanolide as a covalent binding agent.

  2013cites this paper
• Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.

  2013cites this paper
• Zampanolide, a potent new microtubule stabilizing agent, covalently reacts with the taxane luminal site in both tubulin α , β heterodimers and microtubules

  2013influential citation
• Asymmetric and highly stereoselective synthesis of the DEF-ring moiety of (-)-FR182877 and its derivative inducing mitotic arrest.

  2012cites this paper
• Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.

  2012cites this paper
• Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

  2012cites this paper
• Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression

  2012cites this paper
• Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.

  2012cites this paper
• Enantioselective Total Synthesis of (-)-FR182877

  2011cites this paper
• Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules.

  2011cites this paper
• Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies.

  2011cites this paper
• New insights into the mechanisms of cytomotive actin and tubulin filaments.

  2011cites this paper
• What tubulin drugs tell us about microtubule structure and dynamics.

  2011cites this paper
• Fluorescent taxoid probes for microtubule research.

  2010cites this paper
• The Assembly-Inducing Laulimalide/Peloruside A Binding Site on Tubulin: Molecular Modeling and Biochemical Studies with [3H]Peloruside A

  2010cites this paper
• Cyclostreptin and Microtubules: Is a Low‐Affinity Binding Site Required?

  2009cites this paper
• Total synthesis of (-)-FR182877 through tandem IMDA-IMHDA reactions and stereoselective transition-metal-mediated transformations.

  2009cites this paper
• Microtubule stabilising agents for cancer chemotherapy

  2009cites this paper
• The interaction of microtubules with stabilizers characterized at biochemical and structural levels.

  2009cites this paper
• Entropy and Enthalpy in the Activity of Tubulin-Based Antimitotic Agents

  2009cites this paper
• Identification and characterization of molecular targets of natural products by mass spectrometry.

  2009cites this paper
• Biogenesis and Biomimetic Chemistry: Can Complex Natural Products Be Assembled Spontaneously?

  2008cites this paper
• TTI-237: a novel microtubule-active compound with in vivo antitumor activity.

  2008cites this paper
• Cell-Based and Biochemical Structure-Activity Analyses of Analogs of the Microtubule Stabilizer Dictyostatin

  2008cites this paper
• Mechanisms and kinetics of microtubule perturbing agents

  2008influential citation
• Interaction of a cyclostreptin analogue with the microtubule taxoid site: the covalent reaction rapidly follows binding.

  2008cites this paper
• An Overview of Compounds That Interact with Tubulin and Their Effects on Microtubule Assembly

  2008cites this paper
• The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin.

  2008cites this paper
• Strategies for the development of novel Taxol-like agents.

  2007cites this paper
• Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents.

  2007cites this paper
• Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.

  2007cites this paper
• The microtubule-pore gatekeeper.

  2007cites this paper
• Intramolecular Diels-Alder reactions of siloxacyclopentene constrained trienes.

  2007cites this paper
• Promotion of tubulin assembly by poorly soluble taxol analogs.

  2007cites this paper
• Microtubule-stabilizing natural products as promising cancer therapeutics.

  2007cites this paper
• Characterizing ligand-microtubule binding by competition methods.

  2007cites this paper
• Tandem intramolecular Michael-aldol reaction as a tool for the construction of the C-ring of hexacyclinic acid.

  2006cites this paper
• Synergistic Effects of Peloruside A and Laulimalide with Taxoid Site Drugs, but Not with Each Other, on Tubulin Assembly

  2006cites this paper
• Interacciones de los microtúbulos con ligandos activadores de tubulina

  2005cites this paper
• Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.

  2005cites this paper
• PHARMACOLOGICAL AND STRUCTURE-ACTIVITY RELATIONSHIP EVALUATION OF MICROTUBULE-STABILIZING AGENTS

  2005cites this paper